Manual Therapy
Showing 9976 - 10000 of >10,000
Stroke, Hemiplegia, Subcortical Infarction Trial in Seongnam-si, Daejeon (Low-frequency rTMS (experimental), Low-frequency rTMS
Not yet recruiting
- Stroke
- +2 more
- Low-frequency rTMS (experimental)
- Low-frequency rTMS (sham comparator)
-
Seongnam-si, Korea, Gyeonggi-do, Korea, Republic of
- +1 more
Sep 7, 2022
Breast Cancer Trial in Qingdao (HS-IT101)
Not yet recruiting
- Breast Cancer
- HS-IT101
-
Qingdao, Shandong, ChinaThe Affiliated Hospital of Qingdao University
Aug 16, 2022
Malignant Biliary Obstruction Trial in Bournemouth, Manchester (Intraductal Radio-Frequency Ablation, Biliary Stent Placement)
Not yet recruiting
- Malignant Biliary Obstruction
- Intraductal Radio-Frequency Ablation
- Biliary Stent Placement
-
Bournemouth, Dorset, United Kingdom
- +1 more
May 16, 2022
Pulmonary Arterial Hypertension, Pulmonary Hypertension Trial in Canada, United States (Inhaled Nitric Oxide 0.025 mg/kg IBW/hr
Completed
- Pulmonary Arterial Hypertension
- Pulmonary Hypertension
- Inhaled Nitric Oxide 0.025 mg/kg IBW/hr delivered via INOpulse DS Device
- +2 more
-
Birmingham, Alabama
- +50 more
Jul 13, 2022
B-Cell Non Hodgkin Lymphoma, B-Cell Acute Lymphoblastic Leukemia Trial in Hanoi (anti-CD19 CAR T-cells)
Recruiting
- B-Cell Non Hodgkin Lymphoma
- B-Cell Acute Lymphoblastic Leukemia
- anti-CD19 CAR T-cells
-
Hanoi, VietnamVinmec Research Institute of Stem Cell and Gene Technology
Sep 5, 2023
Heart Failure, Mitral Regurgitation Trial in Brescia (MitraClip)
Recruiting
- Heart Failure
- Mitral Regurgitation
- MitraClip
-
Brescia, Lombardy, ItalyMarianna Adamo
Jul 24, 2022
Hypertriglyceridemia Trial in Canada, Netherlands, United States (evinacumab, Placebo)
Active, not recruiting
- Hypertriglyceridemia
- evinacumab
- Placebo
-
Newport Beach, California
- +38 more
Sep 30, 2022
Subacromial Impingement Syndrome Trial in Cornellà De Llobregat (Long Lever Group, Short Lever Group)
Unknown status
- Subacromial Impingement Syndrome
- Long Lever Group
- Short Lever Group
-
Cornellà De Llobregat, Barcelona, SpainCentre de Rehabilitació en Atenció Primària (Institut Català de
Aug 27, 2019
Shorter Versus Extended Course of Antibiotic Therapy for
Not yet recruiting
- Necrotizing Soft Tissue Infection
- Antibiotic duration
-
Orange, CaliforniaUniversity of California Irvine Medical Center
Aug 15, 2023
Immune Thrombocytopenia Trial (Daratumumab Injection)
Not yet recruiting
- Immune Thrombocytopenia
- Daratumumab Injection
- (no location specified)
Sep 28, 2022
Head Neck Cancer, Head and Neck Squamous Cell Carcinoma, Oropharynx Cancer Trial (ENDURE)
Not yet recruiting
- Head and Neck Cancer
- +4 more
- ENDURE
- (no location specified)
Apr 2, 2023
Diabetes, Type 1, Obesity, Childhood, Overweight Trial (Family-Based Treatment for T1D)
Not yet recruiting
- Diabetes Mellitus, Type 1
- +3 more
- Family-Based Treatment for T1D
- (no location specified)
Feb 23, 2023
Non Small Cell Lung Cancer Trial (Osimertinib Mesylate)
Not yet recruiting
- Non Small Cell Lung Cancer
- Osimertinib Mesylate
- (no location specified)
May 18, 2022
Vaccine Response Trial in Atlanta (Atorvastatin, Quadrivalent seasonal influenza vaccine)
Not yet recruiting
- Vaccine Response
- Atorvastatin
- Quadrivalent seasonal influenza vaccine
-
Atlanta, GeorgiaHope Clinic
Aug 29, 2023
Renal Dialysis Trial in Seoul (Meal, Education)
Completed
- Renal Dialysis
- Meal
- Education
-
Seoul, Korea, Republic ofInje University Seoul Paik Hospital
Jul 20, 2022
Mood Disorder (Depressive Episodes) Trial (The mini apps named "SOUL GYM" on the Wechat)
Not yet recruiting
- Mood Disorder (Depressive Episodes)
- The mini apps named "SOUL GYM" on the Wechat
- (no location specified)
May 19, 2023
Chronic Low-back Pain, Insomnia Trial (sleep retraining therapy, sleep health education modules)
Not yet recruiting
- Chronic Low-back Pain
- Insomnia
- sleep retraining therapy
- sleep health education modules
- (no location specified)
May 4, 2023
Among Brazil Receiving Palbociclib Combinations for HR+/HER2-
Recruiting
- Breast Cancer
- Breast Carcinoma
-
Brasilia, Distrito Federal, BrazilInstituto D´Or de Pesquisa E Ensino - Brasília
Aug 15, 2022
Non-Muscle Invasive Bladder Cancer (NMIBC) Refractory to BCG Trial in Canada, United States (TLD-1433 Bladder infusion and
Recruiting
- Non-Muscle Invasive Bladder Cancer (NMIBC) Refractory to BCG
- TLD-1433 Bladder infusion and Photodynamic Therapy
-
Bala-Cynwyd, Pennsylvania
- +10 more
May 6, 2022
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, End Stage Renal Disease Trial in France (Discontinuation (or not
Recruiting
- Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
- End Stage Renal Disease
- Discontinuation (or not initiation) of Immunosuppressive Therapy
- Maintenance (or initiation) of immunosuppressive treatment: Imurel®, Mabthera®,Cellcept®, Cortancyl®
-
Amiens, France
- +54 more
Jan 6, 2023
Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC (American Joint Committee on Cancer) v8, Clinical
Active, not recruiting
- Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC (American Joint Committee on Cancer) v8
- +8 more
- Durvalumab
- +6 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Dec 7, 2021
Hepatocellular Carcinoma Trial in Beijing (Sintilimab, Lenvatinib, radiotherapy)
Recruiting
- Hepatocellular Carcinoma
- Sintilimab
- +2 more
-
Beijing, Beijing, ChinaBeijing Tsinghua Changgung Hospital
Jan 5, 2023